设计,合成,抗炎活性,DFT建模和对接研究新型布洛芬衍生物的设计,合成,抗炎活性,DFT建模和对接研究
Abbas M Abbas1, Hossam H Nasrallah1,2, Ahmed Aboelmagd1
1Chemistry Department, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.
International journal of molecular sciences
|March 28, 2024
概括
一种新型的布洛芬衍生物及其金属复合物显示出增强的抗炎和COX-2抑制潜力. 这些化合物与标准布洛芬相比,具有更好的结合性和药理动力学特征.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 材料科学 材料科学 材料科学
背景情况:
- 炎症和疼痛管理通常依赖于非类固醇抗炎药物 (NSAIDs),如布洛芬.
- 开发具有提高疗效和安全性概况的新型NSAID衍生物是关键的研究领域.
- 了解金属复合物与NSAIDs的结构-活性关系,可以提高治疗性能.
研究的目的:
- 为了合成一种新的布洛芬衍生物, (E) - 2 - 4 - 异布丁) - N - 4 - 氧普坦 - 2 - 伊利丁) 化 (IA).
- 准备和表征IA的金属复合物与 (Co),铜 (Cu), (Ni),加多 (Gd) 和 (Sm).
- 评估合成化合物的抗炎疗效和循环氧化酶-2 (COX-2) 抑制潜力.
主要方法:
- 合成易布洛芬衍生物 (IA) 和其金属复合物.
- 使用1H NMR,质谱学 (MS),里埃变形红外 (FTIR) 光谱学和UV-Vis光谱学进行结构性表征.
- 计算分析包括密度功能理论 (DFT) 和与COX-2酶 (PDB: 5IKT) 的分子对接.
- 使用SwissADME对血脑屏障 (BBB) 透性和胃肠道吸收等参数进行药理动力学评估.
主要成果:
- 成功合成和综合性结构特征的布洛芬衍生物 (IA) 和其金属复合体.
- 确定不同金属离子的独特协调几何形状:Cu/Ni/Co的八面体和Gd/Sm.的封顶方形反 prismatic/tricapped三角 prismatic.
- 分子对接显示,与布洛芬相比,这些化合物对COX-2酶的结合能更强.
- 药物动力学分析表明了有利的特性,包括潜在的BBB透性和胃肠道吸收.
- 显著较低的IC50值显示出增强的抗炎和COX-2抑制活性.
结论:
- 新型布洛芬衍生物 (IA) 和其金属复合物表现出有前途的抗炎和COX-2抑制活性.
- 这些化合物比传统的布洛芬具有更好的结合亲和力和药理动力学特征.
- 这些发现支持了新一代布洛芬衍生品在炎症治疗中具有治疗应用的潜力.
更多相关视频
10:10Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
10.3K
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.3K
相关概念视频
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
